Viewing Study NCT00886769


Ignite Creation Date: 2025-12-24 @ 10:59 PM
Ignite Modification Date: 2026-01-02 @ 4:31 PM
Study NCT ID: NCT00886769
Status: TERMINATED
Last Update Posted: 2017-03-29
First Post: 2009-04-22
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Single-dose Study to Assess Efficacy of Canakinumab (ACZ885) in Patients With Active Juvenile Idiopathic Arthritis (SJIA)
Sponsor: Novartis Pharmaceuticals
Organization: